Inhibition of transforming growth factor beta/SMAD signal by MiR‐155 is involved in arsenic trioxide‐induced anti‐angiogenesis in prostate cancer
Authors:
Open Access
- 5 November 2014
- journal article
- Published by Wiley in Cancer Science
- Vol. 105 (12) , 1541-1549
Abstract
Prostate cancer is the most common cause of cancer‐related deaths in men. Current practices for treatment of prostate cancer are less than satisfactory because of metastasis and recurrence, which are primarily attributed to angiogenesis. Hence, anti‐angiogenesis treatment is becoming a promising new approach for prostate cancer therapy. In addition to treating acute promyelocytic leukemia, arsenic trioxide (As2O3) suppresses other solid tumors, including prostate cancer. However, the effects of As2O3 on angiogenesis in prostate cancer cells, and the underlying molecular mechanisms remain unclear. In the present study, As2O3 attenuated angiogenic ability through microRNA‐155 (miR‐155)‐mediated inhibition of transforming growth factor beta (TGF‐β)/SMAD signal pathway in human prostate cancer PC‐3 and LNCaP cells in vitro and in vivo. Briefly, As2O3 inhibited the activations/expressions of both TGFβ‐induced and endogenous SMAD2/3. Furthermore, As2O3 improved the expression of miR‐155 via DNA‐demethylation. MiR‐155, which targeted the SMAD2‐3′UTR, decreased the expression and function of SMAD2. Knockdown of miR‐155 abolished the As2O3‐induced inhibitions of the TGF‐β/SMAD2 signaling, the vascular endothelial growth factor secretion and angiogenesis. Through understanding a novel mechanism whereby As2O3 inhibits angiogenic potential of prostate cancer cells, our study would help in the development of As2O3 as a potential chemopreventive agent when used alone or in combination with other current anticancer drugs.Keywords
Funding Information
- Natural Science Foundation of China (81100253)
This publication has 35 references indexed in Scilit:
- Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491Toxicology Letters, 2014
- Induction of the mesenchymal to epithelial transition by demethylation‐ activated microRNA‐200c is involved in the anti‐migration/invasion effects of arsenic trioxide on human breast cancer cellsMolecular Carcinogenesis, 2014
- The Pivotal Role of microRNA‐155 in the Control of CancerJournal of Cellular Physiology, 2014
- The cell-cycle interactome: a source of growth regulators?Journal of Experimental Botany, 2013
- VEGF Induces TGF-β1 Expression and Myofibroblast Transformation after Glaucoma SurgeryThe American Journal of Pathology, 2013
- Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathwayToxicology Letters, 2013
- miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast CancerPLOS ONE, 2013
- Recombinant Human Endostatin Endostar Suppresses Angiogenesis and Lymphangiogenesis of Malignant Pleural Effusion in MicePLOS ONE, 2012
- Comparison of Optical and Power Doppler Ultrasound Imaging for Non-Invasive Evaluation of Arsenic Trioxide as a Vascular Disrupting Agent in TumorsPLOS ONE, 2012
- Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalkBreast Cancer Research, 2012